Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languages.
De Nicolo A, Eccles DM, Aaltonen K, Alhopuro P, Ariansen SL, Biancolella M, Caputo SM, Caron O, Cavalli P, Chiang J, Claes KBM, Cuaresma ECS, de la Hoya M, De Pauw A, Díez O, Domínguez-Valentin M, Ehrencrona H, Fjeldvær MK, Fostira F, Francia MBD, Galego-Carro J, Gómez García EB, Hassan NT, Hauke J, Hirasawa A, Huang X, Ilagan-Cargullo EMH, Imoto I, Jonnagadla S, Karthikeyan M, Kleiblova P, Konstantopoulou I, Kowalik A, Kvist A, Lesueur F, Li ST, López-Fernández A, Machackova E, Martins A, Mensenkamp AR, Momozawa Y, Montalban G, Monteiro ANA, Nevanlinna H, Ngeow J, Palmero EI, Pedersen IS, Que FVF, Santamariña M, Santana Dos Santos E, Singer CF, Siołek M, Solano AR, Soukupova J, Suresh PD, Szczepaniak M, Tan YY, Teo SH, Tham E, Thomassen M, Tsaousis G, Hansen TVO, Vega A, Velasco-Sampedro EA, Wangensteen T, Wappenschmidt B, Yannoukakos D, Yoon SY, Spurdle AB, Radice P.
De Nicolo A, et al. Among authors: huang x.
J Med Genet. 2026 May 14:jmg-2026-111498. doi: 10.1136/jmg-2026-111498. Online ahead of print.
J Med Genet. 2026.
PMID: 42135054